Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/12374452

Download in:

View as

General Info

PMID
12374452